Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis

BACKGROUND: Considering the improvement in adherence and convenience, once-monthly paliperidone palmitate (PP1M) has been increasingly used in the treatment of schizophrenia. However, the outcomes for patients who switch from oral antipsychotics (OAPs) to PP1M have not been reliably assessed. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Li, Xin, Ye, Chong, Jia, Miaomiao, Si, Tianmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439041/
https://www.ncbi.nlm.nih.gov/pubmed/37490267
http://dx.doi.org/10.1007/s40263-023-01028-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439041/
https://www.ncbi.nlm.nih.gov/pubmed/37490267
http://dx.doi.org/10.1007/s40263-023-01028-1

Ejemplares similares